Structural basis for the neutralization and genotype specificity of hepatitis E virus

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 25, 2011, Pages 10266-10271

  Tang, Xuhua ^a   Yang, Chunyan ^b   Gu, Ying ^b   Song, Cuiling ^b   Zhang, Xiao ^b   Wang, Yingbin ^b   Zhang, Jun ^b   Hew, Choy Leong ^a,b   Li, Shaowei ^b   Xia, Ningshao ^b   Sivaraman, J ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARAGINE; ASPARTIC ACID; EPITOPE; LEUCINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 8C11; THREONINE; UNCLASSIFIED DRUG; VALINE;

ARTICLE; CRYSTAL STRUCTURE; GENOTYPE; HEPATITIS E VIRUS; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VIRUS LIKE AGENT; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; BINDING SITES; CELL LINE; EPITOPES; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT;

HEPATITIS E VIRUS;

EID: 79960020875     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1101309108     Document Type: Article

References (28)

1. Balayan MS (1993) Hepatitis E virus infection in Europe: Regional situation regarding laboratory diagnosis and epidemiology. Clin Diagn Virol 1:1-9.
2. Purcell RH, Emerson SU (2001) Animal models of hepatitis A and E. ILAR J 42:161-177. (Pubitemid 33708707)
3. Jaiswal SP, Jain AK, Naik G, Soni N, Chitnis DS (2001) Viral hepatitis during pregnancy. Int J Gynaecol Obstet 72:103-108. (Pubitemid 32141078)
4. Tam AW, et al. (1991) Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-length viral genome. Virology 185:120-131.
5. Li S, et al. (2009) Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction. PLoS Pathog 5:e1000537.
6. Yamashita T, et al. (2009) Biological and immunological characteristics of hepatitis E viruslike particles based on the crystal structure. Proc Natl Acad Sci USA 106:12986-12991.
7. Guu TS, et al. (2009) Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci USA 106: 12992-12997.
8. Xing L, et al. (2011) Spatial configuration of hepatitis E virus antigenic domain. J Virol 85:1117-1124.
9. Zhang J, et al. (2005) Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine 23:2881-2892. (Pubitemid 40386490)
10. Holm L, Park J (2000) DaliLite workbench for protein structure comparison. Bioinformatics 16:566-567.
11. Fransson J, et al. (2010) Human framework adaptation of a mouse anti-human IL-13 antibody. J Mol Biol 398:214-231.
12. Al-Lazikani B, Lesk AM, Chothia C (1997) Standard conformations for the canonical structures of immunoglobulins. J Mol Biol 273:927-948. (Pubitemid 27493729)
13. Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372:774-797. (Pubitemid 47321791)
14. Li SW, et al. (2005) Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. J Biol Chem 280:3400-3406.
15. He S, et al. (2008) Putative receptor-binding sites of hepatitis E virus. J Gen Virol 89: 245-249.
16. Purcell RH, Emerson SU (2008) Hepatitis E: An emerging awareness of an old disease. J Hepatol 48:494-503.
17. Worm HC, van der Poel WH, Brandstätter G (2002) Hepatitis E: An overview. Microbes Infect 4:657-666. (Pubitemid 34607415)
18. Lok SM, et al. (2008) Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol 15:312-317.
19. Liu J, Bartesaghi A, Borgnia MJ, Sapiro G, Subramaniam S (2008) Molecular architecture of native HIV-1 gp120 trimers. Nature 455:109-113.
20. Zhu FC, et al. (2010) Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: A large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 376:895-902.
21. Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276:307-326. (Pubitemid 27085611)
22. Storoni LC, McCoy AJ, Read RJ (2004) Likelihood-enhanced fast rotation functions. Acta Crystallogr D Biol Crystallogr 60:432-438. (Pubitemid 41087570)
23. Emsley P, Cowtan K (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60:2126-2132. (Pubitemid 41742764)
24. Brünger AT, et al. (1998) Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54:905-921.
25. Laskowski RA, Macarthur MW, Moss DS, Thornton JM (1993) PROCHECK: A program to check the stereochemical quality of protein structures. J Appl Cryst 26:283-291.
26. Schuck P (2000) Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J 78:1606-1619.
27. Delano W (2002) The PyMOL Molecular Graphics System (Delano Scientific, San Carlos, CA).
28. Gouet P, Courcelle E, Stuart DI, Métoz F (1999) ESPript: Analysis of multiple sequence alignments in PostScript. Bioinformatics 15:305-308. (Pubitemid 29213756)